Exciting News Out of Stockholm for ER+ Resistant Cancer

Options
CypressCynthia
CypressCynthia Member Posts: 4,014 Member
in Breast Cancer #1
Adding the drug everolimus to the aromatase inhibitor exemestane "more than doubled the time women lived without tumor growth and cut risk of their disease worsening by 57% versus hormonal therapy alone." See:
Novartis Drug Helps Women With Advanced Breast Cancer

This from the source below:

"Coupling everolimus with exemestane (an aromatase inhibitor) has produced such dramatic disease control in women with advanced hormone resistant, estrogen receptor-positive breast cancer that it is expected to transform the management of these patients."

Everolimus Posts Big Win in ER-Postive Breast Cancer

http://www.oncologystat.com/news/Everolimus_Posts_Big_Win_in_ER-Positive_Breast_Cancer__US.html

Comments

  • carkris
    carkris Member Posts: 4,553 Member
    #2
    Options
    that is great news CC
    that is great news CC thanks!
  • dbhadra
    dbhadra Member Posts: 344 Member
    #3
    Options
    carkris said:

    that is great news CC
    that is great news CC thanks!

    Wow
    Thanks for posting!
  • Lighthouse_7
    Lighthouse_7 Member Posts: 1,566 Member
    #4
    Options
    dbhadra said:

    Wow
    Thanks for posting!

    Thanks so much!

    Thanks so much!
  • ender
    ender Member Posts: 167
    #5
    Options
    Lighthouse_7 said:

    Thanks so much!

    Thanks so much!

    Thanks for sharing!

    Thanks for sharing!
  • skipper54
    skipper54 Member Posts: 936 Member
    #6
    Options
    ender said:

    Thanks for sharing!

    Thanks for sharing!

    Thanks for sharing!
    Wonder what they consider "advanced"? Still, any good news on the fight.

Discussion Boards